IP Library Granted Patent US 9,119,413
Granted Patent B2
US 9,119,413 · App. 14/144,704 · Granted Sep 1, 2015

Edible energy composition

Inventor: Manoj Bhargava (Farmington Hills, MI)
Assignee: International IP Holdings LLC
A23L1/296A23L1/2367A23L1/30A23L1/302A23L1/3051A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,119,413
App. No.
14/144,704
Granted
Sep 1, 2015
Kind
B2
Abstract

An energy composition includes a methylated xanthine, a choline derivative, and at least one flavorant in a sufficient amount to render the energy composition palatable. The energy composition may also include vitamins, amino acids, preservatives, and the like.

Claims (24)

1. A complete edible energy composition consisting of:

a methylated xanthine in an amount from about 0.0005 g/ml to about 0.005 g/ml;

a choline derivative in an amount from about 0.00005 g/ml to about 0.0009 g/ml;

an edible organic acid;

at least one flavorant;

glucuronolactone;

a preservative;

at least one ingredient selected from the group consisting of vitamin B6, niacin, folate, niacinamide, vitamin B12 and combinations thereof;

at least one ingredient selected from the group consisting of N-acetyl-tyrosine, L-phenylalanine, taurine, and combinations thereof.

2. The edible energy composition of claim 1 wherein said vitamins are present in an amount from 0.0005 g/ml to about 0.008 g/ml.

3. The edible energy composition of claim 1 comprising vitamin B6 in an amount from about 0.0001 g/ml to about 0.003 g/ml; vitamin B12 in an amount from about 0.000001 g/ml to about 0.00003 g/ml; folic acid in an amount from about 0.000005 g/ml to about 0.0002 g/ml; and

niacinamide in an amount from about 0.0001 g/ml to about 0.003 g/ml.

4. The edible energy composition of claim 1 wherein said methylated xanthine is caffeine.

5. The edible energy composition of claim 3 wherein said caffeine is present in an amount from about 0.0016 g/ml to about 0.0040 g/ml.

6. The edible energy composition of claim 1 wherein said choline derivative is citicoline.

7. The edible energy composition of claim 1 wherein said organic acid is malic acid.

8. The edible energy composition of claim 7 said malic acid is present in an amount from about 0.001 to about 0.012 g/ml.

9. The edible energy composition of claim 1 comprising glucuronolactone in an amount from about 0.001 to about 0.012 g/ml.

10. The edible energy composition of claim 1 wherein said preservative is selected from group consisting of sodium benzoate, calcium benzoate, potassium benzoate, magnesium benzoate, potassium sorbate and combinations thereof.

11. The edible energy composition of claim 1 wherein the preservative is a natural preservative.

12. The edible energy composition of claim 1 comprising N-acetyl L-tyrosine in an amount from about 0.001 to about 0.008 g/ml, L-phenylalarline in an amount from about 0.001 to about 0.008 g/ml and taurine in an amount from about 0.001 to about 0.008 g/ml.

13. The edible energy composition of claim 1 comprising vitamin B6; vitamin B12; folic acid; malic acid; niacinamide;

glucuronolactone; N-acetyl L-tyrosine; L-phenylalanine; and taurine.

14. The edible energy composition of claim 1 wherein said flavorant is Sucralose.

Assignments (5)
SECURITY INTEREST Recorded Feb 23, 2023
From: INTERNATIONAL IP HOLDINGS, LLC
To: BMO HARRIS BANK N.A., AS AGENT
Reel/Frame 062778/0478 →
RELEASE OF SECURITY INTEREST Recorded Feb 23, 2023
From: KEYBANK NATIONAL ASSOCIATOIN, AS AGENT
To: INTERNATIONAL IP HOLDINGS, LLC
Reel/Frame 062783/0252 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 14, 2016
From: INTERNATIONAL IP HOLDINGS, LLC
To: KEYBANK NATIONAL ASSOCIATION
Reel/Frame 040312/0355 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2014
From: BHARGAVA, MANOJ
To: BIOCLINICAL DEVELOPMENT INC.
Reel/Frame 033207/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2014
From: BIOCLINICAL DEVELOPMENT INC.
To: INTERNATIONAL IP HOLDINGS LLC
Reel/Frame 033207/0983 →
Continuity (3)
Continuation 13364795 · Feb 2, 2012
Continuation 12139163 · Jun 13, 2008
Related Publication 20140113033A1 · Apr 24, 2014